Efficient synthesis of heterocyclic compounds derived from 2,6-dioxopiperazine derivatives and their evaluation for anti-inflammatory and anticancer activities

被引:7
作者
Kumar, Sandeep [1 ]
Kumar, Nikhil [2 ]
Roy, Partha [2 ]
Sondhi, Sham M. [1 ]
机构
[1] Indian Inst Technol Roorkee, Dept Chem, Roorkee 247667, Uttar Pradesh, India
[2] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttar Pradesh, India
关键词
Synthesis; 2,6-Dioxopiperazine derivatives; Anti-inflammatory; Anticancer; AMIDINE DERIVATIVES; COLON-CANCER; COX-2; DIKETOPIPERAZINES; INHIBITORS; DESIGN; ASSAY;
D O I
10.1007/s00044-014-0969-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Piperazine dione derivatives (1a-j) on condensation with 2,6-pyridine dicarboxylic acid (2x), 3,5-pyridine dicarboxylic acid (2y) and 2,5-thiophene dicarboxylic acid (2z) gave corresponding heterocyclic compounds 3ax-3jz in excellent yields. All the newly synthesized compounds were fully characterized by spectroscopic means and elemental analysis. On screening for anti-inflammatory and for in vitro anticancer activity, compounds 3bx, 3cx, 3dx, and 3ex exhibited good anti-inflammatory activity, whereas compounds 3ay, 3az, 3cz, 3dx, 3ez, 3fx, 3gx, and 3hz exhibited good anticancer activity.
引用
收藏
页码:3953 / 3969
页数:17
相关论文
共 36 条
[1]  
Abraham W.-R., 2005, DRUG DESIGN REV, V2, P13, DOI [10.2174/1567269053390257, DOI 10.2174/1567269053390257]
[2]   Synthesis of amidine and bis amidine derivatives and their evaluation for anti-inflammatory and anticancer activity [J].
Arya, Surbhi ;
Kumar, Nikhil ;
Roy, Partha ;
Sondhi, S. M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 59 :7-14
[3]   A new class of highly cytotoxic diketopiperazines [J].
Boger, DL ;
Fink, BE ;
Hedrick, MP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (10) :1019-1020
[4]   COX-2: A molecular target for colorectal cancer prevention [J].
Brown, JR ;
DuBois, RN .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2840-2855
[5]   Inhibition of plasminogen activator inhibitor-1 activity by two diketopiperazines, XR330 and XR334 produced by Streptomyces sp. [J].
Bryans, J ;
Charlton, P ;
ChicarelliRobinson, I ;
Collins, M ;
Faint, R ;
Latham, C ;
Shaw, I ;
Trew, S .
JOURNAL OF ANTIBIOTICS, 1996, 49 (10) :1014-1021
[6]   The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: Part 2 [J].
Cody, WL ;
Augelli-Szafran, CE ;
Berryman, KA ;
Cai, CM ;
Doherty, AM ;
Edmunds, JJ ;
He, JX ;
Narasimhan, LS ;
Penvose-Yi, J ;
Plummer, JS ;
Rapundalo, ST ;
Rubin, JR ;
Van Huis, CA ;
Leblond, L ;
Winocour, PD ;
Siddiqui, MA .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) :2503-2508
[7]   Synthesis and in vitro evaluation of a series of diketopiperazine inhibitors of plasminogen activator inhibitor-1 [J].
Folkes, A ;
Roe, MB ;
Sohal, S ;
Golec, J ;
Faint, R ;
Brooks, T ;
Charlton, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (19) :2589-2592
[8]   A mouse model for studying the interaction of bisdioxopiperazines with topoisomerase IIα in vivo [J].
Grauslund, Morten ;
Thougaard, Annemette Vinding ;
Fuechtbauer, Annette ;
Hofland, Kenneth Francis ;
Hjorth, Peter Hansen ;
Jensen, Peter B. ;
Sehested, Maxwell ;
Fuechtbauer, Ernst-Martin ;
Jensen, Lars H. .
MOLECULAR PHARMACOLOGY, 2007, 72 (04) :1003-1014
[9]   Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors [J].
Groesch, Sabine ;
Maier, Thorsten Juergen ;
Schiffmann, Susanne ;
Geisslinger, Gerd .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (11) :736-747
[10]   Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung [J].
Harris R.E. .
Inflammopharmacology, 2009, 17 (2) :55-67